El diagnóstico etiológico fue: parálisis supranuclear progresiva y cardiomiopatía . usion_en_el_cuidador/links/portal7.info 6- Ling H, de. Shy-Drager, la Parálisis Supranuclear Progresiva y la Atrofia. Multisistémica. Los estudios investigativos en curso están evaluando los efectos del LSVT en la. Balcells Riba M., Jubert Gruart J., Espadaler Medina J.M.:Parálisis supranuclear progresiva o distonia oculo-facio-cervical. Estúdio de un caso clínico.
|Language:||English, Spanish, French|
|Genre:||Fiction & Literature|
|ePub File Size:||19.88 MB|
|PDF File Size:||20.85 MB|
|Distribution:||Free* [*Sign up for free]|
Information on Paralisis Supranuclear Progresiva/Spanish-language fact sheet on Progressive Supranuclear Palsy. Compiled by the National Institute of. Caracteristicas clinicas de la Paralisis supranuclear progresiva en el INCN. Article (PDF Available) · October with 79 Reads. La parálisis supranuclear progresiva clásica, también conocida como síndrome de Richardson, es la variante por la inestabilidad postural, rigidez progresiva, parálisis visual supranuclear y demencia leve. Resumen; Greek (, pdf).
MRI may show atrophy in the midbrain with preservation of the pons giving a "hummingbird" sign appearance and Mickey Mouse sign  Differential diagnosis[ edit ] PSP is frequently misdiagnosed as Parkinson's disease because they both involve slowed movements and gait difficulty, with PSP being one of a collection of diseases referred to as Parkinson plus syndromes. Both Parkinson's and PSP have an onset in late middle age and involve slowing and rigidity of movement. However, several distinguishing features exist. Tremor is very common with Parkinson's, but rare with PSP. Case reports of rehabilitation programs for patients with PSP generally include limb-coordination activities, tilt-board balancing, gait training , strength training with progressive resistive exercises, and isokinetic exercises and stretching of the neck muscles. Individuals with PSP are often referred to occupational therapists to help manage their condition and to help enhance their independence.
Google Scholar  Anastasopoulos G. A case report. Neuropsychiatrika Chronika, 6, 64—67, In Greek. Google Scholar  Anastasopoulos G. Progressive Supranuclear palsy.
Greek Neurologists and Psychiatrists, Salonica , pp. Google Scholar  Antunes J.
Neurology Minneap. Google Scholar  Anzil A. Case report with pathological findings.
Acta Neuropathol. Folia Phoniat. Google Scholar  Barbeau A. Syndrome de Steele-Richardson-Olszewski. Importanza dei reperti otoneurologici nella diagnosi e nella fisiopatologia della malattia. Nuovo Arch. Google Scholar  Barontini F. Google Scholar  Behrman S. Brain, 92, —, Radiology, , 89—94, Putaminal pigments and nosology.
Brain, 98, —, Paris , , —, Google Scholar  Brusa A. Paris, 43, —, Nuclear ophthalmoplegia, with especial reference to retraction of the lids and ptosis and to lesions of the posterior commissure.
Brain, 50, —, Google Scholar  Cambier J. A propos d'une observation anatomo-clinique. Google Scholar  Cambier J. A propos d'une observation. Google Scholar  Corin M.
Google Scholar  Couet P. Google Scholar  Craus A. Google Scholar  Critchley M. Brain, 52, 23—83, Google Scholar  Curzon G.
Poor response to therapy may be the first clue. Geriatrics, 7, 60—61, Google Scholar  Dalziel J. Age Ageing, 6, —, Atti XXI Cong.
Goetz CG. Charcot on Parkinson's disease. Mov Disord ;1 1 Neurology ;69 5 Louis ED. The shaking palsy, the first forty-five years: a journey through the British literature. Mov Disord ;12 6 Lees AJ. Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's th birthday. Mov Disord ;22 Supl 17 :ss Parent M, Parent A. Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship.
Can J Neurol Sci ;37 3 Marsh L, Margolis RL. Neuropsychiatric aspects of movement disorders. En: Kaplan, Sadock's eds.
Comprehensive textbook of psychiatry. Epidemiological and genetic aspects of neuropsychiatric disorders. Risk of Parkinson disease onset in patients with diabetes.
A 9- year population- based cohort study with age and sex stratifications. Diabetes ; Basal ganglia-thalamocortical circuits : Parallel substrates for motor, oculomotor, prefrontal and limbic functions. Prog Brain Res ; Pakinsonism: onset, progression, and mortality. Neurology ; Fahn S, Elton R. Accesada el 12 de abril de Mov Disord 15 Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.
Lancet Neurol ; Urinary dysfunction in early and untreated Parkinson's disease.
J Neurol Neurosurg Psychiatry ; Ahlskog JE. Cheaper, simpler, and better: Tips for treating seniors with Parkinson disease. Mayo Clin Proc ;86 12 Ann Neurol ;54 1 Parkinson Study Group. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA ; 13 A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease the ADAGIO study : rationale, design, and baseline characteristics.
Mov Disord ;23 15 Parkinson's disease: does vigorous exercise have a neuroprotective effect in Parkinson's disease?
Enfermedad de Parkinson. Practice parameter: Initiation of treatment for Parkinson's disease: an evidence- based review: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Hitzema N, Rafii F. Am Fam Physician ; 80 1 : Leentjens AFG. The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease. A systematic review. Drugs ;71 3 Ten- year follow- up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
Mov Disord ;22 16 The scientific and clinical basis for the treatment of Parkinson disease. Neurology ;72 21 Supl 4 :S1-S Which drugs work best for early Parkinson's disease?
J Fam Pract ;61 2 Schapira A.